Limitations, agreements, and source contact

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma · Source last updated 2016-12-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

limitations And Caveats

description

No overall limitations or caveats for this trial.

point Of Contact

email

kalaycm@ccf.org

organization

Cleveland Clinic

phone

216-444-3705

title

Matt Kalaycio, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice